KeifeRx
Biotechnology ResearchView the employees at
KeifeRx-
Fernando Pagan Professor and Vice Chair Neurology at MedStar Georgetown University Hospital
-
McLean
-
Top 5%
Charbel Moussa Associate Professor of Neurology Georgetown University Medical Center-
Washington DC-Baltimore Area
-
Rising Star
Chris Hoyt Chief Executive Officer at KeifeRx-
Herndon
-
Top 10%
Overview
KeifeRx is an emerging clinical-stage biopharmaceutical company developing novel and optimized, low dose, orally delivered tyrosine kinase inhibitors (TKIs) for the treatment of multiple, high-need neurodegenerative and immune diseases.
-